EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies

Aditya Juloori, Chirag Shah, Kevin Stephans, Andrew Vassil, Rahul Tendulkar

Prostate Cancer · 2016 · 2016 · 1-12

DOI: 10.1155/2016/2420786 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Prostate Cancer, 2016. Verfasst von Aditya Juloori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic, Taussig Cancer Institute, Department of Radiation Oncology, Cleveland, OH, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-risk prostate cancer is an aggressive form of the disease with an increased risk of distant metastasis and subsequent mortality. Multiple randomized trials have established that the combination of radiation therapy and long-term androgen deprivation therapy improves overall survival compared to either treatment alone. Standard of care for men with high-risk prostate cancer in the modern setting is dose-escalated radiotherapy along with 2-3 years of androgen deprivation therapy (ADT). There are research efforts directed towards assessing the efficacy of shorter ADT duration. Current research has been focused on assessing hypofractionated and stereotactic body radiation therapy (SBRT) techniques. Ongoing randomized trials will help assess the utility of pelvic lymph node irradiation. Research is also focused on multimodality therapy with addition of a brachytherapy boost to external beam radiation to help improve outcomes in men with high-risk prostate cancer.

Autor:innen und Institutionen

  • Cleveland Clinic, Taussig Cancer Institute, Department of Radiation Oncology, Cleveland, OH, USA.
  • Cleveland Clinic, Taussig Cancer Institute, Department of Radiation Oncology, Strongsville, OH, USA.

Zitieren

APA

Juloori, A., Shah, C., Stephans, K., Vassil, A., & Tendulkar, R. (2016). Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies. Prostate Cancer, 2016, 1-12. https://doi.org/10.1155/2016/2420786

Vancouver

Juloori A, Shah C, Stephans K, Vassil A, Tendulkar R. Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies. Prostate Cancer. 2016;2016:1-12. doi:10.1155/2016/2420786

BibTeX
@article{Juloori2016,
  author = {Juloori, Aditya and Shah, Chirag and Stephans, Kevin and Vassil, Andrew and Tendulkar, Rahul},
  title = {Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies},
  journal = {Prostate Cancer},
  year = {2016},
  volume = {2016},
  pages = {1--12},
  doi = {10.1155/2016/2420786}
}
Kostenlos starten →